Indutrade acquires microbiology-focused Miclev Medical Products

Published: 4-Jul-2024

Indutrade has signed an agreement to acquire all shares in the Swedish company Miclev Medical Products with annual sales of approximately SEK 130m (US$12.4m)

Indutrade, a Sweden-based technology and industrial business, has acquired Miclev Medical Products.

Miclev Medical Products is a Sweden-based technical trading company specialising in products for detecting, identifying, eliminating, and protecting against microorganisms.

The product offering of Miclev Medical Products includes culture media, diagnostic products, and consumables for safe microbiological processes in sterile cleanroom environments with high quality requirements.

Further, the product offering of Miclev Medical Products caters to the Nordic pharmaceutical and biotech industries. 

Indutrade has signed an agreement to acquire all shares in the Swedish company Miclev Medical Products 

Specifically, through the agreement Indutrade acquired all shares of Miclev Medical Products with annual sales of approximately SEK 130m (US$12.4m).

Bo Annvik, President and CEO of Indutrade, said: "Miclev is a great addition to our group of life science companies. They have a strong product offering and high level of customer service, which in combination with very deep technical expertise and underlying market growth paves the way for continued sustainable, profitable growth."

The product offering of Miclev Medical Products caters to the Nordic pharmaceutical and biotech industries. 

The closing of the agreement took place in July and Miclev Medical Products has been included in the Business Area Life Science department of Indutrade.

The acquisition is Indutrade's twelfth in 2024 and is expected to have a marginally positive impact on Indutrade's earnings per share.  

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.

You may also like